Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma
Oncotarget
.
2023 Jul 1:14:668.
doi: 10.18632/oncotarget.28471.
Authors
Eduard Teixidor
1
,
Elia Sais
1
,
Carmen Amalia Vásquez
2
,
Walter Carbajal
1
,
Alejandro Hernández
1
,
Gloria Sánchez
3
,
Angel Izquierdo
1
,
Sara Verdura
4
5
,
Javier A Menéndez
4
5
,
Joaquim Bosch-Barrera
1
5
6
Affiliations
1
Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona, Spain.
2
Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Catalonia, Spain.
3
Department of Radiology, Diagnostic Imaging Institute, Doctor Josep Trueta University Hospital, Girona, Spain.
4
ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain.
5
Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain.
6
Department of Medical Sciences, Medical School, University of Girona, Girona, Spain.
PMID:
37395727
PMCID:
PMC10317036
DOI:
10.18632/oncotarget.28471
No abstract available
Publication types
Published Erratum